Your browser doesn't support javascript.
loading
Is there a role for chemotherapy and radiation in the treatment of patients with low-grade myofibroblastic sarcoma?
Xu, Y; Xu, G; Wang, X; Mao, M; Wu, H; Baklaushev, V P; Chekhonin, V P; Peltzer, K; Wang, G; Zhang, C.
Afiliación
  • Xu Y; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Xu G; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Wang X; Department of Orthopaedics, Tianjin Hospital, Tianjin, China.
  • Mao M; Department of Epidemiology and Biostatistics, First Affiliated Hospital, Army Medical University, Chongqing, China.
  • Wu H; Department of Pathology and Southwest Cancer Center, First Affiliated Hospital, Army Medical University, Chongqing, China.
  • Baklaushev VP; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Chekhonin VP; Federal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Biomedical Agency of the Russian Federation, Moscow, Russian Federation.
  • Peltzer K; Department of Basic and Applied Neurobiology, Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation.
  • Wang G; Department of Research and Innovation, University of Limpopo, Turfloop, South Africa.
  • Zhang C; Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China. wangguowen@tmu.edu.cn.
Clin Transl Oncol ; 23(2): 344-352, 2021 Feb.
Article en En | MEDLINE | ID: mdl-32607812
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedades Raras / Fibrosarcoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Enfermedades Raras / Fibrosarcoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Año: 2021 Tipo del documento: Article País de afiliación: China